View all IQVIA events
Dr. Obaidullah
Chief Executive Officer, Drug Regulatory Authority of Pakistan (DRAP)
Join us for a virtual session titled Pakistan’s Proven Capability in Hepatitis Delta & MASH Clinical Development, where global clinical leaders will explore Pakistan’s strategic advantages in conducting trials for Hepatitis Delta and MASH therapies.
The webinar will highlight access to large treatment-naïve patient populations, rapid recruitment performance, and streamlined regulatory pathways through DRAP. Attendees will gain insights into high-quality data output from experienced Phase I–IV investigator-led sites and understand Pakistan’s suitability for both innovative and biosimilar development pipelines.
This session is ideal for clinical trial sponsors, pharmaceutical and biotech leaders, and global regulatory professionals evaluating new geographies.
Featured Speakers
Prof. Dr. Saeed Hamid
Professor, Gastroenterology & Director Clinical Trial Unit
Benjamin Laverty
Head of Australia, New Zealand & SEA RDS • Clinical Operations, IQVIA
Mark H DeLegge MD
Senior Medical Director, GI/Hepatology Center of Excellence
Syed Munawar Ali
Head, Clinical Operations, R&DS, Pakistan
Raina Singh Paplikar
Associate Director, Communications, R&DS APAC, IQVIA